sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen diphosphate

Catalog No. :
ACSBNO810
CAS No. :
51855-98-2
Molecular Formula :
C9H14N3NaO11P2
Molecular Weight :
425.16

IUPAC Name:sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen diphosphate

sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen diphosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namesodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen diphosphate
IUPAC Namesodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen diphosphate
Molecular FormulaC9H14N3NaO11P2
Molecular Weight425.16
SMILESNC1=NC(=O)N([C@@H]2O[C@H](COP(=O)(O)OP(=O)([O-])O)[C@@H](O)[C@H]2O)C=C1.[Na+]
InChI KeyCGJORIHRPIQVOS-IAIGYFSYSA-M
SynonymCytidine 5'-(trihydrogen diphosphate), sodium salt (1:);CYTIDINE 5'-(TRIHYDROGEN DIPHOSPHATE), SODIUM SALT;Citicoline Impurity N1 XNa
CAS No.51855-98-2

Synthetic Route by SureRoute

1. ACSBNO810 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSBNO810 route product structure diagram
    ACSBNO81051855-98-2
Inquiry

2. ACSBNO810 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSBNO810 route product structure diagram
    ACSBNO81051855-98-2
Inquiry

Comments (0)